CorVent Medical, a privately held portfolio company of Coridea LLC, is committed to developing smart, versatile, lifesaving ventilators for critical care. The company's first product, the CorVent Single-Use Ventilator, was designed in partnership with Design Catapult, an industrial design firm recognized for their rapid ideation of medical and commercial products. The ventilator is currently pending Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) for ventilators, tubing connectors and accessories, which authorizes its use for the duration of the U.S. Health and Human Services COVID-19 public health emergency declaration. This device is not yet FDA cleared or approved.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
05/11/20 | $4,500,000 | Seed |
Deerfield Foundation Exor Genesis Medtech Group Jim Swartz Redmile Group Sofinnova Partners | undisclosed |